3.
肺癌患者化疗前后不同性别、病理类型、有无转移、文化程度、有无基础病之间的SAS得分(t检验)
The SAS scores of different gender, pathological types, metastasis, educational background and disease history of lung cancer patients before and after chemotherapy (t-test)
| Before chemotherapy | t | P | After 2 cycles | t | P | After 4 cycles | t | P | |
| SAS scores | SAS scores | SAS scores | |||||||
| *P < 0.05. SCLC: small cell lung cancer; NSCLC: non-small cell lung cancer. | |||||||||
| Gender | -0.148 | 0.883 | -0.558 | 0.675 | 0.124 | 0.901 | |||
| Female | 48.93±7.332 | 52.79±8.559 | 54.57±8.671 | ||||||
| Male | 49.19±4.944 | 51.92±5.623 | 54.31±5.932 | ||||||
| Histological types | -0.940 | 0.352 | -0.558 | 0.559 | -0.145 | 0.885 | |||
| SCLC | 50.38±4.629 | 53.08±6.474 | 54.62±5.284 | ||||||
| NSCLC | 54.30±7.421 | 51.92±5.623 | 54.30±7.421 | ||||||
| Metastasis | 1.270 | 0.210 | 0.007 | 0.995 | 0.718 | 0.476 | |||
| Yes | 50.17±4.770 | 52.17±4.896 | 53.67±5.147 | ||||||
| No | 48.15±6.265 | 52.15±7.786 | 55.04±7.942 | ||||||
| Educational background | -0.911 | 0.367 | 0.664 | 0.510 | 0.685 | 0.497 | |||
| ≤9 years | 58.60±0.977 | 51.78±6.774 | 53.97±6.897 | ||||||
| > 9 years | 50.14±1.340 | 53.14±5.829 | 55.43±6.345 | ||||||
| Disease history | -0.886 | 1.388 | -2.394 | 0.675 | -1.287 | 0.204 | |||
| No | 48.68±5.940 | 51.84±6.560 | 54.30±7.421 | ||||||
| Yes | 50.38±4.629 | 53.08±6.474* | 54.62±5.284 | ||||||